Apollo Unveils ‘End-O Check’ for Early Detection of Women’s Cancers

The initiative focuses on identifying endometrial and ovarian cancers, two of the most common gynaecologic cancers, at an early, more treatable stage.

Apollo Cancer Centres (ACCs) has launched End-O Check, an early detection program for women aged 45 and above.

The initiative focuses on identifying endometrial and ovarian cancers, two of the most common gynaecologic cancers, at an early, more treatable stage. It aims to raise awareness of symptoms, support timely diagnosis in high-risk groups, and promote preventive care to encourage women to take proactive measures for their gynaecologic health.

Dr Pakhee Agarwal, Senior Consultant in Gynaecology Oncology and Robotic Surgery at Apollo Cancer Centre, New Delhi, said, “Endometrial cancer has been on the rise in women over 45, so early detection is crucial for better outcomes. Global data indicates a five-year survival rate of around 96 percent for localized disease.

However, survival rates drop substantially when diagnosis is delayed, underscoring the importance of timely detection. Key risk factors include obesity, diabetes, early menstruation, late menopause, and polycystic ovary syndrome (PCOS), all of which are becoming more prevalent among Indian women.”

Highlighting the role of imaging in the program, Dr Reeti, Senior Consultant, Radiology Department, Apollo Cancer Centre, New Delhi, said, “Radiology plays a crucial role in the early detection of gynaecologic cancers. Through End-O Check, we are integrating transvaginal ultrasonography (TVS) as the diagnostic tool to help identify subtle changes that could indicate early-stage ovarian or endometrial cancers. Early imaging intervention allows clinicians to act promptly, improving patient treatment options and outcomes.”

Stay tuned for more such updates on Digital Health News